In a recent announcement, Venable LLP, a major law firm actively engaging within the biotechnological and pharmaceutical industries, has initiated a month-long Life Sciences Webinar Series. The program is set to delve into the intricacies of the life sciences industry and the latest trends that significantly influence its landscape. Details of the event, including dates and topics, are available for further reference.
One of the key features of the Life Sciences Webinar Series is its sector-focused narrative and comprehensive outlook on the ever-evolving legal landscape pertinent to life sciences. The webinars will comprise discussions led by seasoned attorneys from Venable, who boast extensive experience across various practices. They aim to unpack relevant insights and foster a better understanding of the existing legal framework.
The series is set to cover a broad range of topics, with one notable session focusing on the Inter partes review (IPRs), post-grant review (PGRs), and the Biologics Price Competition and Innovation Act (BPCIA). This particularly insightful discussion is scheduled for October 17th, between 1:00 pm and 2:00 pm ET.
The Life Sciences Webinar Series offers legal professionals an invaluable opportunity to stay ahead of the curve and acquaint themselves with the latest developments within the commercial, regulatory, and legal dimensions of the life sciences industry. Furthermore, it presents a unique platform to engage with industry colleagues and thought leaders, navigated by the expert guidance of Venable’s attorneys.
The series is a testament to Venable’s deep-rooted commitment to enriching the legal and professional growth of practitioners in this complex and rapidly-progressing industry.